Icon Plc
Accelerating Drug And Medical Devices Development And Improving Lives

What makes someone or something an icon? Aside from displaying immense talents in whatever field, the lasting and positive effects left by any entity that effectuates revolutionary change beckons the emergence of an iconic presence. And considering how, as a company, ICON plc has thus far successfully persevered in supporting the medical device industry since 1990 with best-in-class manufacturing solutions, the moniker has been rightfully earned.

The market today constantly faces challenges in managing high costs when designing and developing new products, regulations and other government specifications, digitalisation, security, and overall product quality. What causes the higher costs when producing a new product is how long it takes an idea to go from conception to realisation. Setting and executing a properly planned and designed foundation for a project with well-defined specifications is vital to avoid this issue and allow organisations to gain significant return on investment faster. Moreover, the modern healthcare industry has observed clinical data as the most important aspects of any medical research.

However, adhering to stringent clinical data management (CDN) standards to meet the many regulatory requirements makes clinical studies a more complex issue. Additionally, hundreds of clinical data sources and the lack of a standardised data management solution have led to scattered trial data. This has created several workflow gaps whenever users attempt to access relevant information in critical moments during their studies. Companies worldwide are in dire need of an expert solutions provider that can help them overcome these hassles as effectively and affordably possible. And ICON plc stands confidently as the premiere consultancy and services provider, with its ability to integrate unstructured data set from various sources into one consolidated location for seamless access and information delivery.

Revolutionising the Management of Data in Clinical Trials

Having been a player in this space for over three decades, ICON plc expertly outsources pharmaceutical, biotechnology, and medical device development services to effectively run clinical trials for pharmaceutical organisations worldwide. “Scientific communication during the initial phases of product development establishes interest within the scientific and medical community and encourages involvement from patients, investors, and the media in later stages of product development,” explains Dr. Steve Cutler, CEO of ICON plc. He also continues to express that these early communications must be well-informed, internally coordinated and aligned with a company’s future goals to ensure that every asset is represented in the best possible manner to the world of investigators, patients, physicians, and scientists. This goes to illustrate the benefits of early planning, and ICON plc’s team of medical professionals and consultants work towards improving the medical communication between all relevant parties in a study.

According to the CEO, education and information gathering, internal planning, and implementing external tactics are the three main steps a client must follow during the initial product development phases. When executed correctly, the results a client observes are incredibly desirable— saving a significant amount of time and money. ICON plc also supports each study with incredibly nuanced strategies that revolve around launching external communications that present and publish pre-clinical data.

Our dedicated medical device and diagnostics team has the experience, knowledge, and flexibility to meet the unique requirements of both emerging and established manufacturers throughout a product’s lifecycle

ICON plc’s Device Manufacturing Prowess The company offers services in device and therapeutics, clinical operations, regulatory affairs, and quality assurance. “Our dedicated medical device and diagnostics team has the experience, knowledge, and flexibility to meet the unique requirements of both emerging and established manufacturers throughout a product’s lifecycle,” states Dr. Cutler. ICON plc maintains a comprehensive understanding of the niche demands that exist in the market and offers strategic support alongside tactical solutions for various traditional, in vitro diagnostics and a slew of software devices. The company helps its clients navigate the product development processes while providing insights on how a product can be improved. The medical consultancy expert goes the extra mile by assisting each study with commercialisation and reimbursement planning, regulatory compliance consulting, quality systems development and implementation, and several other holistic services.

ICON plc’s experience in delivering services for medical device manufacturing is unparalleled, with impressive expertise in implantable devices, surgical tools, systems, and accessories alongside drug delivery devices, diagnostic imaging and monitoring devices, wireless systems, and mobile medical applications among many others. Under the banner of clinical operations, ICON plc supports its clients with a brilliant team of project and data managers, clinical monitors, biostatisticians, and QA experts. These experts promise each company to help expertly design, implement, and manage clinical trials for various devices to meet and exceed the market’s expectations. The organisation’s adaptive design trials truly display ICON plc’s dedication towards effectuating a client’s success where this novel clinical trial approach effectively maximises the efficiency and portfolio value of each study.

Par Excellence Regulatory Expertise “Our teams are well-versed in the global regulatory and clinical trial requirements for a full range of product uses and can assist in the application of human factors engineering to product design,” says Dr Cutler. Each country has its list of regulations that ought to be followed, and ICON plc offers to carry that burden for clinical trials all over the globe. Its medical device and IVD regulatory experts empower each client with precious and actionable insights on best developing a product to minimise risks and optimise commercialisation. The company ensures to help design and implement cost-effective, sure-fire strategies that bode well in the eyes of FDA, EU, and other international regulatory agencies expeditiously.

The Road Ahead

Over the next few years, ICON plc is set to leverage its data strategies and consultancy services to add more value for clients throughout the medical devices manufacturing space. Currently operating in key market areas across the globe, the company is set to change the medical devices manufacturing game with the benefits of the end patient in mind. Shortly, the company will enhance its services and operations to deliver more cost-effective and high-quality services to its customers in any part of the world.